“`html
Kelyniam Global CFO to Address Life Sciences Virtual Investor Forum
CANTON, Conn., Sept. 15, 2025 – Kelyniam Global (OTC:KLYG), a specialized manufacturer of custom cranial implants, announced today that its Chief Financial Officer, Terrance Kurtenbach, will be a featured presenter at the Life Sciences Virtual Investor Forum on September 18th, 2025.
Event Details:
Date: September 18th
Time: 10:00 AM Eastern Daylight Time
The virtual forum offers a platform for individual and institutional investors, as well as advisors and analysts, to engage with Kelyniam’s leadership and learn more about the company’s growth strategy and innovative product offerings. In addition to the live presentation, the management team will be available for one-on-one meetings on the afternoon of September 18th, as well as on September 19th and 22nd. Interested parties are encouraged to register in advance to schedule meetings.
This interactive online event will allow investors to pose questions to Kelyniam’s management in real-time. For those unable to attend the live presentation, an archived webcast will be available following the event.
Kelyniam is leveraging advancements in computer-aided design and manufacturing (CAD/CAM) to create custom prosthetics using advanced medical-grade polymers. The company’s expertise lies in the rapid production of these implants, allowing for personalized solutions for patients requiring cranial reconstruction. Kelyniam’s strategy centres around direct collaboration with surgeons, healthcare systems and payers to improve treatment outcomes and cost-effectiveness.
The company is also capitalizing on the growing demand for osteointegrative implants. Their exclusive license of the CustomizedBone implant from Finceramica Spa of Italy, coupled with the OsteoStrip and OsteoPlug product lines from Osteopore (Singapore), positions Kelyniam to capitalize on the regenerative medicine space. Analysts suggest that a key growth driver for Kelyniam will be the increased adoption of regenerative technologies in cranial reconstruction, driven by the advantages of improved biocompatibility and faster healing times.
About Kelyniam Global
Kelyniam Global, Inc. specializes in the development, manufacture, and distribution of custom cranial implants.
Disclaimer: This press release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially due to factors including economic conditions, competition, and the company’s ability to execute its business plan. Investors are encouraged to review Kelyniam’s SEC filings for a complete discussion of these risks.
“`
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/9326.html
